Actos FAQ

Actos®(pioglitazone HCl) is a prescription medication used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. Actos® is generally not used for patients with type 1 “juvenile” diabetes or diabetic ketoacidosis.Actos Warning  - Migliore Law -

There are several forms of Actos®

  • Actos®(Pioglitazone HCl)
  • Actoplus Met (a combination of metformin and pioglitazone, prescribed for type 2 diabetes patients who do not use daily insulin injections.
  • Actoplus Met XR (Pioglitazone HCl and Metformin HCI), an extended release tablet.
  • Duetact, a 2 in 1 medication that contains a combination of glimepiride and pioglitazone and is used for patients with type 2 diabetes who do not use daily insulin injections and is sometimes given with other diabetes medications when greater blood sugar control is needed.

What are some of the problems with Actos®?

Actos® has a black box warning, for its increased risk of heart attack and new studies are linking the drug to an increased risk bladder cancer.

Is Actos® still on the market?

Actos® is still available for purchase in the United States, but France and Germany have taken the medication off the market. Britain’s agency responsible for regulating the safety and effectiveness of drugs and medical devices issued a drug safety update on Actos (pioglitazone) in August 2011.

A French study looked at over one million subjects and concluded that patients taking Actos® were at a 22% higher risk of developing bladder cancer than those who had not taken the drug. A U.S. study, which the FDA reviewed, indicated up to a 40% increased risk of developing bladder cancer in patients who took Actos® for longer than one year.

Who is most at risk for developing bladder cancer while taking Actos®?

The chance of developing bladder cancer with Actos® use increases the longer a patient has been taking it. Those who have the higher cumulative doses are greater at risk.

What steps has the FDA taken?

In September 2010, the Food and Drug Administration announced that they were reviewing preliminary safety information on Actos®. Then, in June 2011, the FDA issued an “urgent health warning” relating to the bladder cancer risk of Actos® and approved new labeling on Actos® to include information on the bladder cancer risk. The FDA has continued to monitor new information and studies conducted in the U.S. and in Europe. While Actos® is no longer on the market in some European countries, the drug remains readily available in the U.S.

What are my legal options if I developed bladder cancer after taking Actos®?

After you have begun treatment for bladder cancer, it is important to contact an Actos® lawyer to protect your legal rights. A product liability lawyer can evaluate your case and determine whether you have grounds for a lawsuit and the best way to proceed in the legal system. If we accept your case, our firm will review your medical records and begin a lawsuit on your behalf.

Are there Actos lawsuits currently filed with the court?

Yes, Actos® lawsuits have already been filed. Victims who have developed bladder cancer after taking Actos still have time to file to a claim.

Call for a Free Case Evaluation

The law firm of Rudolph F.X. Migliore, P.C. is now accepting Actos® bladder cancer cases. With over three decades of experience with personal injury cases, the firm has the knowledge and expertise to help Actos® victims.

Our New York firm works with nationally recognized co-counsel to reach major verdicts, while providing clients with local, personalized service. If you or a loved one has taken Actos® and has developed bladder cancer or need further information about a potential case investigation, email us or call our office at 631-543-3663. Take advantage of our free case evaluations and find out if you have grounds for a lawsuit.

Contact Our Firm

Navigation